Aeternum Health (AETN) Return on Capital Employed (2011 - 2026)

Aeternum Health has disclosed Return on Capital Employed across 16 years of filings, most recently posting 35.71% for Q1 2026.

• In Q1 2026, Return on Capital Employed fell 236.0% year-over-year to 35.71%; the TTM figure through Mar 2026 stood at 35.71% (down 236.0% YoY), while the FY2025 annual figure was 25.08%, down 3783.0% from the prior year.
• Return on Capital Employed climbed to 35.71% in Q1 2026, from 25.18% in the prior quarter.
• Over the last five years, Return on Capital Employed for AETN reached as high as 534.67% in Q4 2023 and fell as low as 525.01% in Q3 2023.
• The 5-year median for Return on Capital Employed is 25.18% (2025), against an average of 36.32%.
• The widest YoY moves for Return on Capital Employed: up 65892 bps in 2023, down 34883 bps in 2023.
• A 5-year view of Return on Capital Employed shows it stood at 124.25% in 2022, then jumped by 530 bps to 534.67% in 2023, then slumped by 89 bps to 56.44% in 2024, then tumbled by 55 bps to 25.18% in 2025, then soared by 42 bps to 35.71% in 2026.
• According to Business Quant data, Return on Capital Employed over the past three periods registered 35.71%, 25.18%, and 32.75% for Q1 2026, Q4 2025, and Q3 2025 respectively.